| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/gpb/CoronellSHGBHLM18 |
| P356 | DOI | 10.1016/J.GPB.2017.10.002 |
| P932 | PMC publication ID | 6000238 |
| P698 | PubMed publication ID | 29505855 |
| P2093 | author name string | Andreas Weinhäusel | |
| Peter Hettegger | |||
| István Gyurján | |||
| Andrea Gsur | |||
| Gernot Leeb | |||
| Karl Mach | |||
| Philipp Hofer | |||
| Johana A Luna Coronell | |||
| Khulan Sergelen | |||
| Stefanie Brezina | |||
| P2860 | cites work | Multiple tumors and a novel E2F-4 mutation. A case report | Q73061912 |
| Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer | Q83180901 | ||
| Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk | Q83865336 | ||
| The pre-analytical processing of blood samples for detecting biomarkers on protein microarrays | Q86715218 | ||
| Comparative proteomic study for profiling differentially expressed proteins between Chinese left‐ and right‐sided colon cancers | Q87361284 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Gene ontology: tool for the unification of biology | Q23781406 | ||
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| mTOR signaling in growth control and disease | Q24634174 | ||
| The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website | Q24645514 | ||
| A census of human cancer genes | Q24647081 | ||
| Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2 | Q24648193 | ||
| WebGestalt: an integrated system for exploring gene sets in various biological contexts | Q24813284 | ||
| The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications | Q26779166 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies | Q28208804 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX | Q28219302 | ||
| Characterization of human colon cancer antigens recognized by autologous antibodies | Q28272525 | ||
| Axin, an inhibitor of the Wnt signalling pathway, interacts with β‐catenin, GSK‐3β and APC and reduces the β‐catenin level | Q28282155 | ||
| Natural Innate and Adaptive Immunity to Cancer | Q29620313 | ||
| Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types | Q30423124 | ||
| Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates | Q30538531 | ||
| Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. | Q30739293 | ||
| Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations | Q30751781 | ||
| Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. | Q30881744 | ||
| Adjustment of systematic microarray data biases | Q30886734 | ||
| Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma | Q31115820 | ||
| Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies | Q31126986 | ||
| The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning. | Q33204775 | ||
| Tumor associated antigen recognition by autologous serum in patients with breast cancer. | Q33209639 | ||
| Serological analysis of human renal cell carcinoma | Q33228634 | ||
| Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). | Q33329447 | ||
| Profiling tumor-associated autoantibodies for the detection of colon cancer | Q33331295 | ||
| Autoantibodies as potential biomarkers for breast cancer | Q33332063 | ||
| Next-generation high-density self-assembling functional protein arrays | Q33333441 | ||
| Analysis of gene expression data using BRB-ArrayTools. | Q33448521 | ||
| Multiple serological biomarkers for colorectal cancer detection | Q33507935 | ||
| Protein Array-based Approaches for Biomarker Discovery in Cancer | Q33632268 | ||
| Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens | Q33747137 | ||
| Using Proteomic Approach to Identify Tumor-Associated Proteins as Biomarkers in Human Esophageal Squamous Cell Carcinoma | Q33881201 | ||
| Immunogenicity of autoantigens | Q33949907 | ||
| An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays | Q34215799 | ||
| MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer. | Q35857510 | ||
| Human Blood Autoantibodies in the Detection of Colorectal Cancer | Q36068902 | ||
| Protein-detecting microarrays: current accomplishments and requirements. | Q36080618 | ||
| WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 | Q36954017 | ||
| The immune system and inflammation in breast cancer | Q37033451 | ||
| Epigenetics and colorectal cancer pathogenesis | Q37061792 | ||
| HDACs and HDAC inhibitors in colon cancer | Q37104507 | ||
| The footprints of cancer development: Cancer biomarkers | Q37343214 | ||
| Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. | Q37379645 | ||
| Clinical significance of tumor markers and an emerging perspective on colorectal cancer | Q37387757 | ||
| Causal analysis approaches in Ingenuity Pathway Analysis | Q37592031 | ||
| Important molecular genetic markers of colorectal cancer. | Q37619856 | ||
| High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers. | Q37688939 | ||
| Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer | Q37711623 | ||
| Colorectal cancer proteomics, molecular characterization and biomarker discovery. | Q37817279 | ||
| Molecular pathways in colorectal cancer. | Q38018369 | ||
| The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics | Q38030295 | ||
| The secretome in cancer progression. | Q38094482 | ||
| Monitoring the immune competence of cancer patients to predict outcome | Q38184391 | ||
| Biomarkers of colorectal cancer: recent advances and future challenges | Q38259770 | ||
| The secretome of colon cancer stem cells contains drug-metabolizing enzymes | Q39128903 | ||
| Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma | Q39460592 | ||
| MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway. | Q39744343 | ||
| Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. | Q40165870 | ||
| Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses | Q40664080 | ||
| Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer | Q42492006 | ||
| Comparative protein profiling of serum and plasma using an antibody suspension bead array approach | Q43232328 | ||
| ARChip epoxy and ARChip UV for covalent on-chip immobilization of pmoA gene-specific oligonucleotides | Q44926551 | ||
| Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer | Q48098677 | ||
| The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG. | Q52874472 | ||
| Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer. | Q54458965 | ||
| Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer | Q71398694 | ||
| P4510 | describes a project that uses | RStudio | Q4798119 |
| P433 | issue | 1 | |
| P921 | main subject | in silico | Q192572 |
| colon cancer | Q18555025 | ||
| P304 | page(s) | 73-84 | |
| P577 | publication date | 2018-02-01 | |
| P1433 | published in | Genomics Proteomics and Bioinformatics | Q15814350 |
| P1476 | title | The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling | |
| P478 | volume | 16 |
| Q95832579 | Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer | cites work | P2860 |
Search more.